Neurotech International (ASX:NTI)

Latest Article

Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism

Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism

Leading medical device company Neurotech International (ASX:NTI) this week reported highly promising results from US clinical trials of its Mente autism device.

READ ARTICLE

Related Neurotech International (ASX:NTI) articles

Revolutionary MedTech Device: a New Frontier in Autism Treatment

Revolutionary MedTech Device: a New Frontier in Autism Treatment

Today’s company has created the first and only regulated medical device for the management of autism in a home setting.

READ ARTICLE

Top Trending